Press "Enter" to skip to content

New patent expiration for Boehringer Ingelheim drug TRADJENTA

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Boehringer Ingelheim drug TRADJENTA

Annual Drug Patent Expirations for TRADJENTA
Annual Drug Patent Expirations for TRADJENTA

Tradjenta is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from two suppliers. There are thirteen patents protecting this drug and one Paragraph IV challenge.

TRADJENTA drug price trends.

Drug patent litigation for TRADJENTA.

This drug has two hundred and ninety-two patent family members in forty-four countries.

The generic ingredient in TRADJENTA is linagliptin. Two suppliers are listed for this compound. Additional details are available on the linagliptin profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for Boehringer Ingelheim drug TRADJENTA
    Do NOT follow this link or you will be banned from the site!